Clinical Trial Update: Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating PF-07220060 in combination with letrozole for adults with HR-positive, HER2-negative breast cancer who have not received prior…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• PF-07220060

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING